Business Units and Joint Ventures

Macrophage Therapeutics, a newly formed subsidiary of Navidea Biopharmaceuticals, Inc., through use of the Manocept platform, a patented delivery system targeting CD206 on activated macrophages, is seeking to develop treatments for cancer, cardiovascular , autoimmune, antiviral and brain diseases.